.png){kind=logo}
Careers
Join us to make every day a better day for people with diabetes.
Build your future at MiniMed
Our Mission is to make every day a better day for people with diabetes.
MiniMed is the only company that commercializes all parts of a connected diabetes ecosystem for intensive insulin management including insulin pumps, continuous glucose monitors (CGMs), smart insulin pens, and data software. For over 40 years, we’ve reimagined diabetes technology to be smarter, more precise, and a step ahead so people can spend less time managing and more time living.
8K+
Global employees
80+
Countries served
640k+
Customers globally
Cutting-edge diabetes tech that changes lives
At MiniMed, our future is driven by bold innovation and an unwavering commitment to the people we serve. We are advancing the next generation of intelligent insulin delivery systems—designed to simplify diabetes management, enhance precision, and inspire greater confidence every day. Our focus has always been creating technology that works quietly in the background, handling the mental math of diabetes so people can experience more freedom in their daily lives.
Better days start with how we support our people
We believe people do their best work when they feel supported, valued, and connected to meaningful impact—so we’ve designed a total rewards experience that supports life at work and beyond.
Competitive performance-based pay that grows with your career and recognizes the value and impact you make.
Comprehensive benefits that support your health, wellbeing, and everyday life—for you and your loved ones.
Time off that supports rest, balance, and the ability to step away and return ready to do your best work.
Career development that offers opportunities to learn, grow, and explore new paths as your career evolves.
Financial security through programs and resources that help you plan ahead and build long-term stability.
Purpose-driven work through innovation that helps make life with diabetes lighter, easier, and more livable for people around the world.
For us, diabetes is personal
Many of our employees have a personal connection to diabetes, bringing empathy and lived understanding to everything we create.
"I love working for MiniMed because it gives me the opportunity to use my 15+ experience living with type 1 diabetes to inform the work I do every day. I'm grateful my insights are valued."
Lynda, Senior Social Media Specialist, USA
"Living with diabetes and relying on this technology myself, I know what truly matters. The chance to help someone make the right choice in their care is what drives me every day."
Daito, Sales Rep, Diabetes, East Japan
"Living with diabetes means I feel every daily challenge and every small win. It’s humbling to work alongside so many people who care about making my life with diabetes easier."
Daire , Sr Customer Marketing Manager, Ireland
"Being a MiniMed employee means I get to advocate for a technology that has genuinely transformed my own life".
John, Account Manager, Toronto, Ontario
Every day I’m able to share my experience using a MiniMed pump – how it’s made on my own life and the life of all T1’s around me better.
Alexandra, NSW State Manager, Sydney, Australia
Supporting the diabetes community
Giving back is part of who we are. We actively support the diabetes community through partnerships with local and national diabetes organizations, volunteer opportunities and community engagement, and advocacy efforts focused on access and better care.
We believe the strongest companies don’t just operate in communities — they invest in them.
#MiniMedChampions in action
Check out these MiniMed Champions who are redefining what diabetes looks like.
Alexander Zverev, pro tennis player living with T1D
Ines Abrantes, trainer, TV personality and official T1D Barbie ambassador
Jaylen, working professional who travels often with T1D
Jennifer Stone, ER nurse, actor and diabetes advocate
Brooke, lives an active lifestyle with T1D
Our global locations
MiniMed is a global leader in insulin delivery, constantly advancing therapies that support people with diabetes in more than 80 countries. Headquartered in Northridge, California, we have major offices and facilities across North America, Europe, and Asia-Pacific.
Equal employment opportunity information
MiniMed is committed to providing equal opportunity in employment to all.
Know your rights
Equal employment opportunity statement
Pay transparency nondiscrimination provision
MiniMed job applicant privacy notice
Los Angeles county fair chance ordinance
Beware of fraudulent job postings from people claiming to be recruiters for MiniMed.
Recruitment fraud information
Follow life at MiniMed
Connect with us to watch big ideas come to life.
Better days start now – join us!
Important Safety Information: MiniMedTM 780G system with SmartGuardTM technology with Instinct sensor, Simplera SyncTM sensor, and GuardianTM 4 sensor
The MiniMedTM 780G system is intended for the continuous delivery of basal insulin at selectable rates and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose vales in the fluid under the skin.
The MiniMedTM 780G System includes SmartGuardTM technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera SyncTM and GuardianTM 4 sensors and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.
WARNING: Do not use the SmartGuardTM feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuardTM feature.
WARNING: Do not use MiniMedTM 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of MiniMedTM 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuardTM feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including accessories and additional important safety information concerning indications, contraindications, warnings and precautions associated with the system and its components, please consult https://www.minimed.com/important-safety-information and the appropriate user guide at https://www.minimed.com/support/download-library.
©2026 MiniMed. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2026 Abbott. TM*Third–party brands are trademarks of their respective owners.
DreaMed Diabetes is a trademark of DreaMed Diabetes, Ltd. The MiniMedTM 780G system algorithm includes technology developed by DreaMed Diabetes.
Important Safety Information: InPen system
The InPen system consists of a reusable insulin pen and mobile app and is for people living with diabetes. It can be used to deliver insulin, help calculate insulin doses, and estimate carbohydrates for meals. Those under the age of 7 should only use the device with an adult’s supervision. A healthcare provider must prescribe InPen, provide dosage settings, and discuss all potential benefits and risks. Using the device with incorrect therapy settings may lead to severe highs and lows. The system should not be used by those unable to test blood glucose levels or the visually impaired. For additional product and important safety information, see https:www.minimed.com/en-us/important-safety-information.html#smart-pen-system